Replies to post #2115 on Quanta Inc (fka QNTA)

[powerbattles]

I just read the news again and thinking this is much bigger than I thought...

(OTC PINK: QNTA), announced today the Company has renewed a product registration certificate for its lead drug candidate Escozine® from the Ministry of Health in the Dominican Republic (DR). The registration enables Escozine® to be prescribed as a natural bioactive alternative medicine to be used in cancer treatments as well as a treatment for the SARS-CoV-2 (COVID-19) virus, after Medolife performed a safety and efficacy study on COVID-19. This registration in the DR through in-place trade agreements opens the door for distribution and sales in most of Latin America.

The registration was renewed after the Company provided study data on the efficacy of Escozine® in assisting cancer treatments of various kinds including common types of cancer such as breast, prostate, lung, and some uncommon forms of cancer such as bladder and ovarian. The registration allows for Escozine® to be marketed as a bioactive alternative cancer medicine across the DR and most other countries in Latin America, where the burden of cancer and mortality rates are among the highest in the world. Latin America has a combined population of over 400 million people with over one million diagnosed with cancer annually, let alone those being treated for ongoing cancer-related issues. With this registration, the Company is able to negotiate distribution agreements with pharmaceutical chains and distributors throughout Latin America to bring Escozine® to this in-need population. The Company also plans to negotiate with the government in the DR for the purchase of Escozine® for use as a treatment for COVID-19.

https://www.globenewswire.com/news-release/2021/05/04/2222245/0/en/Medolife-Rx-Announces-Historic-Product-Registration-in-Dominican-Republic-Enabling-Escozine-to-Be-Sold-Throughout-Latin-America-as-Natural-Alternative-Cancer-Medicine.html